Related Experiment Video
Updated: Apr 19, 2026
04:36
Noninvasive Electrocardiography in the Perinatal Mouse
Published on: June 12, 2020
6.9K
Discoveries in peripartum cardiomyopathy
James D Fett1, David W Markham2
1Cardiovascular Institute, University of Pittsburgh Medical Center, Pittsburgh, PA; Department of Adult Medicine, Hospital Albert Schweitzer, Deschapelles, Haiti.
Trends in Cardiovascular Medicine
|January 6, 2015
Summary
Peripartum cardiomyopathy (PPCM) outcomes have improved, with most patients recovering fully. Early diagnosis and new interventions are crucial for those with severe PPCM symptoms.
Area of Science:
- Cardiology
- Maternal Health
- Heart Disease Research
Background:
- Peripartum cardiomyopathy (PPCM) is a significant cause of maternal mortality and morbidity globally.
- High incidence rates are observed in the USA, Haiti, and South Africa.
- Recent advancements have led to improved outcomes for PPCM patients.
Purpose of the Study:
- To review the evolving landscape of peripartum cardiomyopathy (PPCM).
- To highlight discoveries and interventions facilitating PPCM recovery.
- To emphasize the need for increased PPCM awareness.
Main Methods:
- Review of recent studies and clinical data on PPCM outcomes.
- Analysis of diagnostic criteria, including ejection fraction (LVEF) and left ventricular dimensions (LVEDd).
- Identification of patient subgroups with varying recovery probabilities.
Main Results:
- Most PPCM patients diagnosed with LVEF > 0.30 achieve recovery (LVEF ≥ 0.50).
- Patients with severely depressed systolic function (LVEF < 0.30) and left ventricular remodeling (LVEDd ≥ 60mm) show the poorest recovery rates.
- These severe cases represent a critical need for novel interventional strategies.
Conclusions:
- Continued efforts to raise PPCM awareness are essential.
- Full recovery is achievable for the majority of PPCM subjects with timely diagnosis and appropriate management.
- Development of new interventions is critical for patients with severe PPCM and poor prognostic indicators.
Related Concept Videos
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
924
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
924
01:30Cardiomyopathy II: Dilated Cardiomyopathy
807
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
807
01:25Cardiomyopathy I: Introduction and Classification
870
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
870
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
806
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
806
01:19Pericarditis II: Clinical Features and Diagnostic Tests
587
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
587
01:27Myocarditis II: Clinical Features and Diagnostic Tests
472
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
472